ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,975.38
0.55%
US Tech 100
20,988.40
0.03%
다우존스 지수
42,706.56
0.00%
Bitcoin
100,901.74
-1.35%
Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 영국
  5. LSE

  6. Centessa Pharmaceuticals Plc (0ACX) 시세

Centessa Pharmaceuticals Plc

Centessa Pharmaceuticals Plc (0ACX)

LSE
0.00
0.00
( 0.00% )
업데이트: -
15분 지연

포트폴리오 강화: 실시간 토론 및 실행 가능한 거래 아이디어.

프리미엄

주요 통계 및 세부정보

가격
-
매수가
-
매도가
-
거래량
-
0.00 일간 변동폭 0.00
0.00 52주 범위 0.00
market_cap
-
전일 종가
-
개장가
-
최근 거래 시간
마지막 거래 시간
-
재정 규모
-
VWAP
-
평균 볼륨(3m)
-
발행 주식
0.00
배당수익률
-
주가수익률
0.00
주당순이익(EPS)
-
매출
6.85M
순이익
-151.09M

Centessa Pharmaceuticals Plc 정보

섹터
Coml Physical, Biologcl Resh
산업
Coml Physical, Biologcl Resh
웹사이트
www.centessa.com
본부
Cheshire, Gbr
설립됨
-
Centessa Pharmaceuticals Plc is listed in the Coml Physical, Biologcl Resh sector of the 런던증권거래소 with ticker 0ACX. The last closing price for Centessa Pharmaceuticals was -. Over the last year, Centessa Pharmaceuticals shares have traded in a share price range of US$ 0.00 to US$ 0.00.

Centessa Pharmaceuticals currently has 0 shares in issue.

0ACX 최신 뉴스

추가 뉴스

Centessa Pharmaceuticals Reports Financial Results for the Third Quarter of 2024 and Provides Business Update

Centessa Pharmaceuticals Reports Financial Results for the Third Quarter of 2024 and Provides Business Update Announced additional interim data from ongoing Phase 1 clinical study of ORX750, a...

12 11월 2024
UK Regulatory

Centessa Pharmaceuticals Announces Pricing of Upsized $225,000,000 Public Offering of American Depositary Shares

Centessa Pharmaceuticals Announces Pricing of Upsized $225,000,000 Public Offering of American Depositary Shares BOSTON and LONDON, Sept. 12, 2024 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals...

13 9월 2024
UK Regulatory

Centessa Pharmaceuticals Announces $150,000,000 Proposed Public Offering of American Depositary Shares

Centessa Pharmaceuticals Announces $150,000,000 Proposed Public Offering of American Depositary Shares BOSTON and LONDON, Sept. 11, 2024 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq:...

12 9월 2024
UK Regulatory

Centessa Announces Positive Interim Phase 1 Clinical Data with its Novel Orexin Receptor 2 (OX2R) Agonist, ORX750, in Acutely Sleep-Deprived Healthy Volunteers

Centessa Announces Positive Interim Phase 1 Clinical Data with its Novel Orexin Receptor 2 (OX2R) Agonist, ORX750, in Acutely Sleep-Deprived Healthy Volunteers 2.5 mg dose restored normative...

10 9월 2024
UK Regulatory

Centessa Pharmaceuticals Announces Late-Breaking Poster Presentation of Non-Human Primate Data for ORX142, a Novel Orexin Receptor 2 (OX2R) Agonist, at the 27th Congress of the European Sleep Research Society (Sleep Europe 2024)

Centessa Pharmaceuticals Announces Late-Breaking Poster Presentation of Non-Human Primate Data for ORX142, a Novel Orexin Receptor 2 (OX2R) Agonist, at the 27th Congress of the European Sleep...

27 8월 2024
UK Regulatory

Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the Second Quarter of 2024

Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the Second Quarter of 2024 Company advancing pipeline of potential best-in-class orexin receptor 2 (OX2R) agonists...

13 8월 2024
UK Regulatory
기간변동변동 %시가고가저가평균 일일 거래량VWAP
10000000DE
40000000DE
120000000DE
260000000DE
520000000DE
1560000000DE
2600000000DE

0ACX - Frequently Asked Questions (FAQ)

What is the current Centessa Pharmaceuticals share price?
The current share price of Centessa Pharmaceuticals is US$ 0.00
What is the 1 year trading range for Centessa Pharmaceuticals share price?
Centessa Pharmaceuticals has traded in the range of US$ 0.00 to US$ 0.00 during the past year
What is the reporting currency for Centessa Pharmaceuticals?
Centessa Pharmaceuticals reports financial results in USD
What is the latest annual turnover for Centessa Pharmaceuticals?
The latest annual turnover of Centessa Pharmaceuticals is USD 6.85M
What is the latest annual profit for Centessa Pharmaceuticals?
The latest annual profit of Centessa Pharmaceuticals is USD -151.09M
What is the registered address of Centessa Pharmaceuticals?
The registered address for Centessa Pharmaceuticals is 3RD FLOOR, 1 ASHLEY ROAD, ALTRINCHAM, CHESHIRE, WA14 2DT
What is the Centessa Pharmaceuticals website address?
The website address for Centessa Pharmaceuticals is www.centessa.com
Which industry sector does Centessa Pharmaceuticals operate in?
Centessa Pharmaceuticals operates in the COML PHYSICAL, BIOLOGCL RESH sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
RCGHRc365 Holding Plc
1.55p
(72.22%)
1.35M
SCGLSealand Capital Galaxy Limited
4.05p
(30.65%)
4.25M
TIGTeam Internet Group Plc
117.60p
(29.23%)
1.45M
S247Smarttech247 Group Plc
12.50p
(28.21%)
400.17k
VRCIVerici Dx Plc
5.00p
(17.65%)
1.02M
GBPGlobal Petroleum Limited
0.2175p
(-25.00%)
476.69M
MINMinoan Group Plc
0.425p
(-22.73%)
7.97M
TM1Technology Minerals Plc
0.12p
(-22.58%)
68.51M
TIRTiger Royalties And Investments Plc
0.125p
(-16.67%)
230.45M
AYMAnglesey Mining Plc
0.625p
(-16.67%)
3.5M
TRPTower Resources Plc
0.0405p
(2.53%)
612.75M
GBPGlobal Petroleum Limited
0.2175p
(-25.00%)
476.69M
DGIDg Innovate Plc
0.02p
(0.00%)
291.4M
NTVONativo Resources Plc
0.002p
(0.00%)
239.67M
TIRTiger Royalties And Investments Plc
0.125p
(-16.67%)
230.45M

토론

전체 피드 보기
prototype_101 prototype_101 3 분 전
Lebby's departure was a BUSINESS STRATEGY decision because Lebby was being TOO STUBBORN on the deal making, so now the BOD installed a true seasoned DEAL MAKER but Shorts continue to post any false narrative they can to get Longs to sell their shares

I believe MrLWLG's post summarize
ASM LWLG
PROPHET-of-PROFITS PROPHET-of-PROFITS 3 분 전
See how he left out the ceo discussion? How and why h2 will be better than h1? Still did 40m euros with an improved margins. selected what he wanted and not what was there. I ignore jagoffs like that clown
RDAR
eastunder eastunder 4 분 전
yesterdays gaps

https://www.stockscores.com/chart.asp?TickerSymbol=amd&TimeRange=30&Interval=d&Volume=1&ChartType=CandleStick&Stockscores=None&ChartWidth=500&ChartHeight=250&LogScale=None&Band=&avgType1=SMA&movAvg1=&avgType2=SMA&movAvg2=&Indicator1=None&Indicator2=&Indicator3=&Indicat
Jackxkr Jackxkr 4 분 전
Especially to those afflicted.
NWBO
Ricco79 Ricco79 4 분 전
Trump Admin II has time until the 11/2026 midterms. Only until then is there a majority in the senate and house of representatives. Theoretically time until November 2028, but neither makes sense. He activated Musk to save taxes. To streamline the state. Trump already cut corporate taxes the first
FNMA
Stinger2014 Stinger2014 4 분 전
Would someone in this newly merged company please step up to the plate!! Tell us why you want/need to trade on the OTC? No dilution, no news, PINK CURRENT.
CGAC
Debunkinator Debunkinator 5 분 전
That's $8.35 Mil in the last 2 months. You do the math for a year $$$$😁🚂
ASII
RKMKE RKMKE 5 분 전
As i have understood and heard, nothing gonna happen in 2025 and also they started the token to learn how the apps work and they should that they are master of tokenization as per my understanding.

I think more than Ken, these pathetic shameless physco pumpers are spreading false rumo
WDLF
fredscott36 fredscott36 6 분 전
.....NO BOWEL MOVEMENTS on the infamous POS cusip pile...........???........

....impossible to predict or forecast, given the history of these LIBOR cases; ours and the related case are the last two (Madoff's is a "friend of the court?")...

...what's weird is when the F
glenn1919 glenn1919 6 분 전
VRME.......POAI......QBTS......ARBE.......SPRC........................https://stockcharts.com/h-sc/ui?s=QBTS&p=D&yr=0&mn=2&dy=12&id=p84071410134
POAI QBTS SPRC
cdate cdate 6 분 전
I see a new employee was hired by Jammy’s and Bubbles boss. Came out swinging to impress them. There getting desperate!
ELTP
ElectricMountain53 ElectricMountain53 7 분 전
As a matter of fact, if we would have listened to the "shorts" we would already have been filthy rich imo. But no, we listened to the positive posters and hoped it would come true. But it didn´t so far. Then some longs became critical thinkers and started asking bittered questions and that seems to
LWLG
Trooperstocks Trooperstocks 7 분 전
$COEP NEWS: Coeptis Therapeutics Announces First Customer Adoptions of its NexGenAI Marketing Platform
PR Newswire
Tue, January 7, 2025 at 8:00 AM EST 6 min read


In This Article:
COEP
+22.55%
COEPW
+3.46%

Coeptis Secures
COEP
gp22 gp22 7 분 전
$SVMH @ .06: Social media rocking on $SVMH....next 300% gainer....Giant volume so far.
SVMH
stocktowatch stocktowatch 7 분 전
$XONI Xtreme Fighting Championships Relaunches Young Guns Series at Kill Cliff Fight Club Live on January 29th, 2025 https://finance.yahoo.com/news/xtreme-fighting-championships-relaunches-young-142700259.html?soc_src=social-sh&soc_trk=tw&tsrc=twtr
XONI
capgain capgain 7 분 전
As of this morning, Hurts is still iffy at best. I'm still waiting on that one, off to the day job.

HAGO.
AveragePenny AveragePenny 8 분 전
$CBDL CBD Life Sciences, Inc. (CBDL) Secures Breakthrough Walmart Marketplace Approval for Mushroom Supplement, Setting the Stage for Unprecedented Growth

https://www.accesswire.com/964487/cbd-life-sciences-inc-cbdl-secures-breakthrough-walmart-marketplace-approval-for-mushroom-supple
CBDL
AveragePenny AveragePenny 8 분 전
$CBDL CBD Life Sciences, Inc. (CBDL) Secures Breakthrough Walmart Marketplace Approval for Mushroom Supplement, Setting the Stage for Unprecedented Growth

https://www.accesswire.com/964487/cbd-life-sciences-inc-cbdl-secures-breakthrough-walmart-marketplace-approval-for-mushroom-supple
CBDL
Debunkinator Debunkinator 9 분 전
As i said-It will all come together soon.
GlobeTopper achieved $4.3 million in revenue for December 2024.
ASII
glenn1919 glenn1919 9 분 전
CTOR.....INAB......INVZ.....ERNA......BHAT......MULN..........................https://stockcharts.com/h-sc/ui?s=MULN&p=D&yr=0&mn=2&dy=12&id=p84071410134
BHAT CTOR INAB
TheRealMrPirate TheRealMrPirate 9 분 전
Formerly #09072Q106 - FKA bioaq
I hope my posting doesn't bother you 🤷
This is a public forum discussing a defunct company - " FKA ".
xodcode xodcode 10 분 전
Outlook for Anavex Investors The future holds exciting potential for Anavex investors. If the trends observed in trial data are realized at a broader scale, Blarcamesine could revolutionize Alzheimer’s treatment, moving from symptom management to prevention in its earliest stages. This would signifi
AVXL JPM
Mr. Dragon Mr. Dragon 11 분 전
Hiding dilution by not updating the share structure is a sleazy tactic. Even the worst tickers in the OTC, like HCMC and PHIL for example, have updated their share structure as recently as a few days ago. The last update for DPLS was on back on NOVEMBER 22, 2024.

Denny will tell y
DPLS HCMC
Debunkinator Debunkinator 11 분 전
Wow=Freakin awesome. $$$$ Weeeeeeeeeeeeeeeeeeeeeeeeee
ASII
Huggy Bear Huggy Bear 11 분 전
Makes for a good story to tell over and over though.

And the Chorus joins in.....
HMBL

최근 히스토리

LSE
0ACX
Centessa Pharmaceuticals
BIT
I07030
INTESA SANPAOLO
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2025 ADVFN PLC - 모든 권리 보유